Granata Bio Corporation

BiotechnologySeries ADuxbury, USgranata.bio

Latest round

Series A

Last raised

Dec 2024

Total raised

$28M

Investors

6

About Granata Bio Corporation

Founded in 2018 and based in Massachusetts, US, Granata Bio Corporation operates as a biopharmaceutical firm that focuses on identifying and marketing important drugs for the health and infertility of women.

Who invested in Granata Bio Corporation

6 investors across 2 rounds

See all investors in Granata Bio Corporation

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 19, 2024

    Amount

    $14M

    Investors

    Locked

  2. Series A

    Jan 16, 2024

    Amount

    $14M

    Investors

    Locked

Questions about Granata Bio Corporation

Who invested in Granata Bio Corporation?

Granata Bio Corporation has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Granata Bio Corporation raised?

Granata Bio Corporation has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Granata Bio Corporation last raise money?

Granata Bio Corporation's most recent round on record is a Series A, in Dec 2024.

What does Granata Bio Corporation do?

Founded in 2018 and based in Massachusetts, US, Granata Bio Corporation operates as a biopharmaceutical firm that focuses on identifying and marketing important drugs for the health and infertility of women.

Where is Granata Bio Corporation headquartered?

Granata Bio Corporation is headquartered in Duxbury, US.

Which VCs invest in companies like Granata Bio Corporation?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Granata Bio Corporation's stage. Their profiles are linked below.

Raising like Granata Bio Corporation? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.